Nitric oxide synthase-3 deficiency results in hypoplastic coronary arteries and postnatal myocardial infarction

Yin Liu1, Xiangru Lu, Fu-Li Xiang

  • 1Department of Physiology and Pharmacology, Western University, London, Ontario, Canada N6A 5C1.

European Heart Journal
|October 11, 2012
PubMed

Insights

Nitric oxide synthase-3 (NOS3) is crucial for coronary artery development. Its deficiency causes hypoplastic coronary arteries, a condition linked to sudden cardiac death.

Area of Science:

  • Cardiovascular Biology
  • Developmental Biology
  • Molecular Medicine

Background:

  • Hypoplastic coronary artery disease is a rare congenital condition.
  • Sudden cardiac death is a known complication.
  • The underlying molecular mechanisms remain unclear.

Purpose of the Study:

  • To investigate the role of nitric oxide synthase-3 (NOS3) in the development of hypoplastic coronary arteries.

Main Methods:

  • Utilized wild-type, NOS3-deficient, and cardiac-specific NOS3-overexpressing mouse models.
  • Assessed coronary artery development, cardiac morphology, and gene expression.
  • Evaluated epicardial cell migration.

Main Results:

  • NOS3 deficiency led to hypoplastic coronary arteries and myocardial infarction in mice.
  • Reduced coronary artery diameter, vessel density, and volume were observed.
  • NOS3 deficiency altered cardiac structure and down-regulated key developmental genes.

Conclusions:

  • Nitric oxide synthase-3 is essential for normal coronary artery development.
  • NOS3 deficiency results in hypoplastic coronary arteries.
  • Restoration of NOS3 expression rescued the observed abnormalities.
Abstract

Related Concept Videos

Nitric Oxide Signaling Pathway01:28

Nitric Oxide Signaling Pathway

Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure to...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...